3 recruiting, 2 not yet recruiting, 1 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow CCUS Clonal Cytopenia of Undetermined Significance: new trials by email Literature Review of CCUS Clonal Cytopenia of Undetermined Significance trials Research Report on CCUS Clonal Cytopenia of Undetermined Significance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dresden MDS Registry With an Accompanying Biomaterial Collection MDS (Myelodysplastic Syndrome), MDS/Myeloproliferative Neoplasm (MPN) Overlap Syndrome | Not yet recruiting | Technische Universität Dresden | 500 | 2026-09-01 | 2026-08-27 | |
| Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis Oral Decitabine and Tetrahydrouridine, Matched Placebo (Capsules) - Clonal Cytopenia of Uncertain Significance, CCUS Clonal Cytopenia of Undetermined Significance | Phase 2 | Not yet recruiting | Clinical Hub for Interventional Research (CHOIR) | 80 | 2026-04-13 | 2026-02-27 |
| CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research Clonal Hematopoiesis, CCUS Clonal Cytopenia of Undetermined Significance | Recruiting | Clinical Hub for Interventional Research (CHOIR) | 100 | 2026-03-20 | 2026-05-13 | |
| Luspatercept for Clonal Cytopenias of Uncertain Significance Luspatercept - CCUS Clonal Cytopenia of Undetermined Significance, Anemia | Phase 2 | Recruiting | Weill Medical College of Cornell University | 50 | 2025-03-25 | 2026-03-24 |
| Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial Enasidenib - Clonal Cytopenia of Undetermined Significance, CCUS Clonal Cytopenia of Undetermined Significance | Phase 2 | Recruiting | Washington University School of Medicine | 15 | 2024-10-10 | 2026-08-10 |
| A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance Enasidenib - Clonal Cytopenia of Undetermined Significance, CCUS Clonal Cytopenia of Undetermined Significance | Phase 1 | Completed | Memorial Sloan Kettering Cancer Center | 4 | 2021-10-06 | 2026-01-27 |
Anemia (1) · Anemia, Refractory, with Excess of Blasts (1) · Disease (1) · Hematologic Diseases (1) · Leukopenia (1) · Neutropenia (1) · Thrombocytopenia (1)
Hemic and Lymphatic Diseases (3) · Hematologic Diseases (2) · Agranulocytosis (1) · Anemia (1) · Anemia, Refractory (1) · Blood Platelet Disorders (1) · Bone Marrow Diseases (1) · Cytopenia (1) · Leukocyte Disorders (1) · Myelodysplastic Syndromes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
enasidenib (2) · Capsules (1) · Decitabine (1) · Tetrahydrouridine (1) · luspatercept (1)
Clinical Hub for Interventional Research (CHOIR) (2) · Memorial Sloan Kettering Cancer Center (1) · Technische Universität Dresden (1) · Washington University School of Medicine (1) · Weill Medical College of Cornell University (1)
United States (3) · Australia (2) · Germany (1)
Eytan Stein, MD (1) · Giulia Petrone, M.D. (1) · Pinkal Desai, MD (1)